The International Diabetes Federation (IDF) officially recognized a fifth form of diabetes in 2025, after decades of ...

Some Texans on SNAP say the ban on using food stamps to buy sugary drinks and candy prevents quick fixes to low blood sugar ...

A trial testing new treatments aimed at restoring warning signs of low blood glucose in people with type 1 diabetes who can no longer perceive when their blood sugars dip dangerously low is underway.

Type 1 diabetes requires people to balance the amount of insulin they are using with their food and activity, and even though many rely on continuous glucose monitors, symptoms such as shaking or ...

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best healthcare penny stocks to buy according to hedge funds. On March 16 ...

Hundreds of thousands of people with diabetes could benefit from a new device that can predict when they will be hit by low ...

But a renowned new device could play a key role in blood sugar regulation, offering level forecasts within 30 minutes. The ...

A substance with all the proven benefits of GLP-1-based drugs, but without their contraindications. It would be a panacea — ...

Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.

A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...

Executives from Biomea Fusion (NASDAQ:BMEA) discussed the company’s lead diabetes program, icovamenib, and outlined near-term clinical milestones during a recent company event hosted by an operator ...